When conducting human tests, Big Pharma did not think twice before using hospitals in certain developing countries, which don’t have "rigorous controls" for such actions, William Jones, a former White House correspondent and a non-resident fellow of the Chongyang Institute for Financial Studies said.
The documents contain information pertaining to such companies as Pfizer, AstraZeneca, Celltrion, Novatris International AG, Merck KGaA, and a branch of Samsung that produces medical equipment. The tests were carried out while the Kiev regime held Mariupol until May 2022, when Russia took over the city.
Patients of the Mariupol hospital's psychiatric ward were most likely used as vulnerable "guinea pigs" in experiments that would not have been permitted in the countries where these pharmaceutical firms are located, William Jones, a former White House correspondent for Executive Intelligence Review and a non-resident fellow of the Chongyang Institute for Financial Studies, Renmin University of China, told Sputnik.
"It has generally been a practice to use some of the developing countries which don’t have such rigorous controls for these types of experiments," Jones noted, hinting at Ukraine.
After the 2014 Maidan coup in Kiev, the country "effectively became a ‘guinea pig’ for whatever experiments the forces of the Western elites had in store for them, as we see most dramatically in the way in which the ‘nation’ of Ukraine is being whittled down to nothing for the sake of NATO’s surrogate war against Russia," according to the expert.
He also touched upon the issue of “the extensive network of biological labs that have been set up in Ukraine over the twenty years, largely with the help, and no doubt at the behest, of the United States,” something that Jones recalled had repeatedly been pointed out by Lieutenant General Igor Kirillov, the head of the biological and chemical warfare department of the Russian Defense Ministry.
"Given the present situation in Ukraine with the growing understanding that Ukraine – or NATO - cannot ‘win’ this conflict using conventional weapons, as well as the determination of NATO not to accept a peaceful resolution unless Russia is soundly defeated, it could well lead to the utilization of some form of biological warfare on the part of NATO to ‘even the playing field’," Jones warned.
In the spring of 2022, Russia's Radiological, Chemical, and Biological Defense Troops brought to light the alarming scope of US military-biological activities taking place at numerous locations in Ukraine. These investigations revealed the collaboration between Washington and Kiev in researching and handling various highly dangerous pathogens. Subsequently, several of these findings have been independently corroborated.
Western Pharmaceutical Companies Used Infants for Testing Drugs in Mariupol
Infants were allegedly used by major Western pharmaceutical companies for testing drugs during experiments that were held on patients of the psychiatric ward of the Mariupol hospital, according to documents seen by Sputnik.
These documents were discovered by builders in the basement of hospital No. 7 in Mariupol during its restoration.
According to the documents, babies were used for experiments conducted in the psychiatric ward of the Mariupol hospital. The list of patients who were administered one of the drugs included infants under one year old. The drug was also administered to children aged from one to 11 years.
Such companies like Pfizer, AstraZeneca, Celltrion, Novatris International AG, IQVIA, Sanofi, Galapagos NV, Janssen Pharmaceuticals, AbbottLaboratories, Covance, Merck KGaA, CentocorBiopharmaceutical and a pharmaceutical branch of Samsung were mentioned in the documents.
©Sputnik
West’s Big Pharma Conducted Drug Testing on Mariupol's Psychiatric Patients for Years
According to documents obtained by Sputnik, major Western pharmaceutical companies, with the assistance of Ukrainian officials, purportedly conducted testing of rheumatological drugs on patients in a Mariupol psychiatric ward for several years.
During the restoration of hospital No. 7 in Mariupol, a construction team stumbled upon a collection of documents in the basement.
These findings of interest turned out to be records from a hospital psychiatric ward, dating from 2008 to 2016. Upon examination, these documents detailed a series of human experiments involving certain undisclosed drugs, which were solely identified by numbers.
The primary purpose of the research was to evaluate the effectiveness of the drug in relation to the proportion of patients who achieved the response according to the criteria of the American College of Rheumatology (ACR).
Companies including Pfizer, AstraZeneca, Celltrion, Novatris International AG, IQVIA, Sanofi, Galapagos NV, Janssen Pharmaceuticals, AbbottLaboratories, Covance, Merck KGaA, CentocorBiopharmaceutical and a biopharmaceutical branch of Samsung were mentioned in the documents.
No comments:
Post a Comment